Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 1;12(1):e2020048.
doi: 10.4084/MJHID.2020.048. eCollection 2020.

Pidotimod in Paucisymptomatic SARS-CoV2 Infected Patients

Claudio Ucciferri  1   2 , Mirko Barone  3 , Jacopo Vecchiet  1 , Katia Falasca  1
Affiliations

Pidotimod in Paucisymptomatic SARS-CoV2 Infected Patients

Claudio Ucciferri et al. Mediterr J Hematol Infect Dis. .
No abstract available

Keywords: COVID-19; Immunomodulatory; Safety; Treatment.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no conflict of Interest.

Figures

Figure 1
Figure 1
Scattered plot (Group A vs Group B) and fever defervescence.
See this image and copyright information in PMC

References

    1. Wu C, Chen X, Cai Y, Xia J, Zhou X, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Mar 13; doi: 10.1001/jamainternmed.2020.0994. doi: 10.1001/jamainternmed.2020.0994. [Epub ahead of print] - DOI - DOI - PMC - PubMed
    1. Barone M, Ucciferri C, Cipollone G, Mucilli F. Recombinant Human Angiotensin-Converting Enzyme 2 and COVID-19 Acute Respiratory Distress Syndrome: A Theoretical or a Real Resource? EJMO. 2020;4(2):139–140. doi: 10.14744/ejmo.2020.47992. - DOI
    1. Xu Z, Shi L, Wang Y, Zhang J, Huang L, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 Apr;8(4):420–422. doi: 10.1016/S2213-2600(20)30076-X. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18. - DOI - DOI - PMC - PubMed
    1. Puggioni F, Alves-Correia M, Mohamed MF, Stomeo N, Mager R, et al. Immunostimulants in respiratory diseases: focus on Pidotimod. Multidiscip Respir Med. 2019 Nov 4;14:31. doi: 10.1186/s40248-019-0195-2. doi: 10.1186/s40248-019-0195-2. eCollection 2019. - DOI - DOI - PMC - PubMed
    1. Borghi MO, Fain C, Barcellini W, Del Papa N, La Rosa L, Nicoletti F, Uslenghi C, Meroni PL. Ex vivo effect of pidotimod on peripheral blood mononuclear cell immune functions: Study of an elderly population. Int J Immunotherapy. 1994;10:35–9.